COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
CY1125824T1Undetermined Publication Date: 2026-04-17NEUROPORE THERAPIES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100070T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-03-27
- Filing Date
- 2023-02-08
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-02-08
Abstract
The present disclosure relates to compounds, pharmaceutical compositions consisting of corresponding compounds, and to the use of corresponding compounds in methods of treatment or pharmaceutical compositions for the treatment of inflammatory diseases and certain neurological disorders associated with inflammatory signaling processes, including, but not limited to, misfolded proteins.
Need to check novelty before this filing date? Find Prior Art